Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027497 (nausea)
 23,468 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A therapeutic regimen is described for sedative, analgesic, and anti-emetic effect in patients receiving intra-arterial carmustine (BCNU) for malignant gliomas. This regimen consists of nalbuphine, 30 mg, i.v., and droperidol, 2.5 mg, i.v., given immediately prior to intra-carotid BCNU infusion. Droperidol, 2.5 mg, i.v., is then administered on four hour intervals for sixteen hours post-procedure. This combination provided excellent effect in nine patients treated for twelve intra-carotid infusions. None of the nine patients experienced vomiting, one experienced mild nausea several hours post-infusion, and non complained of severe pain or discomfort. Thirteen additional patients received diazepam, 10 mg, P.O., prior to the intra-carotid BCNU infusion, with fentanyl, 100 mcg, i.v., and prochlorperazine, 10 mg, i.m. at the onset of infusion. All thirteen patients suffered from severe nausea, vomiting, and orbital pain. The nalbuphine/droperidol combination is thought to provide a superior alternative to the traditional narcotic/pheonothiazine/benzodiazepine combination for carotid BCNU infusion. This combination has theoretical advantages for the patient with intracranial mass lesions by providing analgesia and sedation with minimal potential for respiratory depression and carbon dioxide retention.
 ...
PMID:Nalbuphine and droperidol in combination for sedation and prevention of nausea and vomiting during intra-carotid BCNU infusion. 395 77

Ten healthy normal volunteers received an intravenous infusion of erythromycin lactobionate over 60 min to a total dose of 800 mg (n = 9), and 524 mg (n = 1). Blood samples were collected at 10 min intervals for 100 min and gastric contents aspirated, via a nasogastric tube, from pre-dose to 105 min after start of infusion. Incidence and severity of three gastrointestinal symptoms (nausea, stomach discomfort and feelings of hunger), two CNS symptoms (dizziness and faintness) and a 'control' symptom (back pain) were measured using 100 mm visual analogue scales. Rate of infusion and plasma erythromycin concentration correlated with nausea (P less than 0.001) and stomach discomfort (P less than 0.001); plasma erythromycin concentration was also correlated with dizziness (P less than 0.05). Concentrations of active erythromycin in the aspirate were pH dependent. In one subject the concentration of erythromycin in the aspirate exceeded that in the plasma by 100 fold. Bile staining of samples containing the highest levels of microbiologically active erythromycin makes the origin of the erythromycin in these samples uncertain.
 ...
PMID:Gastrointestinal side effects after intravenous erythromycin lactobionate. 396 30

The complaints and dietary habits of sixteen patients with gastritis and fourteen with undefined abdominal pain were studied by recording method. The results showed that the symptoms of the patients with gastritis and undefined abdominal pain were similar and mostly postprandial and they can be regarded as local (abdominal pain, meteorism, discomfort and heartburn) and/or general (sweating, nausea and faintness). The patients have variations of the symptomatic and asymptomatic periods. The symptomatic patients with gastritis have significantly higher number of daily meals than the asymptomatic patients with gastritis. The daily intake of food, energy and nutrients are low especially in the symptomatic patients with gastritis. It is concluded that the symptoms experienced by the patients with gastritis or undefined abdominal pain are related to the eating so that the daily dietary habits are disturbed. The produced a low intake of food, energy and nutrients especially in the patients with symptomatic gastritis.
 ...
PMID:The complaints and dietary habits of the patients with gastritis and undefined abdominal pain. 399 61

Twenty-one patients with primary empty sella were studied with computed tomography iopamidol cisternography. Ten milliliters of iopamidol at a concentration of 200 mg I/mL was administered intrathecally via the lumbar route. Eleven patients had a partial and 10 a complete empty sella. In six cases the third ventricle had prolapsed to the level of the interclinoid plane. There was no relationship between the clinical presentation and the grade of empty sella. The quality of the images obtained was always good or excellent. Cisternographies were performed in all of the patients although in 13 of them the correct diagnosis could have been achieved with a standard contrast-medium-enhanced computed tomography scan. The overall complication rate was 29%. Four patients (19%) had mild headaches and nausea; two patients (10%) had more severe side effects: vomiting, discomfort, and meningism. Computed tomographic cisternography with low-concentration iopamidol is a safe diagnostic procedure that allows a definite visualization of the anatomic alterations that occur in patients with empty sella. We think that this procedure should always be employed in symptomatic patients.
 ...
PMID:Computed tomographic cisternography with iopamidol in the diagnosis of primary empty sella. 401 53

Dietary habits and eating related symptoms were studied by one week recording method in thirteen successive out-patients attending the routine control following total gastrectomy and Roux-en-Y reconstruction for carcinoma of the stomach. All the patients except one had daily eating related symptoms such as difficulties in swallowing or/and rapid filling of the stomach, or/and discomfort, meteorism and pain, or/and nausea, faintness, sweating and rapid pulse. The number of daily meals was high (eight to fifteen) and the amounts of food eaten small, consisting of one sandwich, or one fruit, or one glass of milk, especially in those patients with most symptoms and most frequent meals. The daily intake of energy (7.4 +/- 2.0 and 6.8 +/- 1.5 MJ in the males and females, respectively) and nutrients was low, and there were no differences between the daily energy intakes by the patients with eight or fifteen daily meals. Thus, it is concluded that in the out-patients following total gastrectomy and Roux-en-Y reconstruction for carcinoma of the stomach, the symptoms related to eating are common and frequent, what causes the high number of daily meals and decreases the quality of life of the patients. The meals of the patients are simple and the patients are prone to a reduced nutritional state due to the low intake of energy and nutrients.
 ...
PMID:Dietary habits and eating related symptoms in out-patients following total gastrectomy and Roux-en-Y reconstruction for carcinoma of the stomach. 401 41

Subdiaphragmatic vagotomy suppresses food intake and water intake in normal rats. Since human patients report some nausea and discomfort following vagotomy, the present study assessed the aversive consequences of vagotomy in rats using a conditioned taste aversion paradigm. Rats were given a total subdiaphragmatic vagotomy or sham vagotomy, and were then maintained on either plain water (Vag-Water and Sham-Water groups) or a novel cherry solution (Vag-Cherry and Sham-Cherry groups). When subsequently tested for their water vs. cherry preferences on postoperative days 6, 16, and 26, the Vag-Cherry group displayed a greater aversion to the cherry solution than did the remaining three groups. This result suggests that vagotomy produces visceral malaise in rats which may contribute to the feeding and drinking suppressive effects of the surgery.
 ...
PMID:Aversive effects of vagotomy in the rat: a conditioned taste aversion analysis. 403 11

The purpose of the present study was to investigate the effects on driving ability of the new analgesic ethyl-N-(2-amino-6-(4-fluor-phenylmethylamino) pyridin-3-yl) carbamate (flupirtine, D 9998) in comparison with pentazocine and placebo. Flupirtine was tested in a double blind cross-over experiment in 12 healthy volunteers using 7 different tests which are known to correspond to the most important aspects of driving ability. Subjects were given 3 consecutive doses of flupirtine of 100 mg each and tested following the first and third administration. The comparison drug pentazocine and placebo were administered in the same dosage regimen (a single dose of pentazocine amounting to 50 mg). Significant differences between flupirtine and placebo could not be detected. Following single dosage of pentazocine subjects more often reported a general feeling of discomfort, including nausea, dizziness and motion sickness, than was the case after administration of flupirtine. While single administration of pentazocine did not produce any significant differences from placebo, multiple administration resulted in both objective and subjective fatigue symptoms. It was concluded that flupirtine, in contrast to pentazocine, did not produce any impairment in driving ability in healthy volunteers.
 ...
PMID:[The effect of the analgesic flupirtine on automobile driving]. 403 55

Eighteen patients received repeated administrations of cisplatin in relatively large amounts (55-75-100 mg/m2) given systemically by drop infusion. As antiemetic treatments, the following were scheduled: on the day before; prednisolone 30mg (3 X p.o.), immediately before; methylprednisolone 500mg (i.v.), and 3 hours after administration of cisplatin ; methylprednisolone 500mg (i.v.) and domperidone 60 mg (suppo.). Domperidone was given twice a day for one week. Nausea, vomiting and anorexia were studied objectively for two weeks. At a dose of 75 mg/m2 of cisplatin, the occurrence and the duration of nausea and vomiting were effectively reduced by the regimen; nausea was observed in 67% of all cases (average duration: 3.3 days) and vomiting was experienced in 40% (1.2 days). Anorexia was observed in 67% of cases and lasted longer (5.2 days). The severity and duration of these side effects of nausea, vomiting and anorexia seemed to appear in a manner related to the dose of cisplatin given, but even at a dose of 100 mg/m2, the regimen described above reduced the patients' discomfort to acceptable levels. No remarkable side effect of this anti-emetic regimen was evident.
 ...
PMID:[Effect of combined use of adrenocortical hormones and domperidone as anti-emetics during cisplatin therapy]. 403 53

150 women participated in a double-blind clinical trial comparing 2 dosages of an oral contraceptive agent: 250 mcg d-norgestrel + 50 mcg ethinyl estradiol and 150 mcg d-norgestrel + 30 mcg ethinyl estradiol. The 150/30 combination resulted in shorter cycles, longer menses (p.001), shorter latent period (p.001), and a higher instance of breakthrough bleeding and spotting (p.05 and p.001). The 250/50 dose caused a significantly higher incidence of breast discomfort (p.001), leg cramps (.02), and nausea (.001). More 250/50 dose women dropped out for more than 1 reason than in the lower dose group.
 ...
PMID:A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol. 420 42

Forty female out-patients undergoing therapeutic abortion participated in a double-blind study comparing flunitrazepam 0.05 mg . kg-1 with thiopentone 6.0 mg . kg-1 as induction agents for general anaesthesia. Induction time, as measured by the time to loss of lid reflex and voluntary speech, was not only significantly longer in patients receiving flunitrazepam, but also much more variable and imprecise than with thiopentone. The Steward recovery room scores and psychomotor drawing test results revealed that recovery was significantly slower in the flunitrazepam group. Anterograde amnesia was observed in all patients who had received flunitrazepam and in one patient who had received thiopentone. No retrograde amnesia was found in either group. Flunitrazepam produced postoperative drowsiness, sedation, ataxia and nausea while with thiopentone discomfort from surgery and discomfort at the intravenous injection site were the main complaints. Because of the slowness of induction with flunitrazepam and marked individual variation, we do not feel that this drug can be considered a suitable agent for routine induction of general anaesthesia.
 ...
PMID:Comparison of flunitrazepam and thiopentone for induction of general anaesthesia. 610 7


<< Previous 1 2 3 4 5 6 7 8 9 10